drugset / Trial / NCT02807428
Study to Evaluate Safety/Efficacy of a Single Preop Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
The objectives of this study are to evaluate the safety and analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing unilateral total knee arthroplasty.
Timeline
- Start
- 2017-02-20
- Primary completion
- 2017-10-23
- Completion
- 2017-12-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brivoligide | Unknown | 660 mg | Intrathecal |
Indications
No indication recorded.